Sutro Biopharma
Price & Volume
Stats
See more52W Range | $5.23-$21.50 |
Market Cap | $79M |
Shares Short | 404,777 |
Financials
See moreRevenue (12 Mos) | $105.6M |
Revenue Growth (YoY) | 13.8% |
Gross Profit (12 Mos) | $274.1M |
Diluted EPS | -$2.60 |
News
See moreYahoo Finance • 28 days ago
Sutro Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
Yahoo Finance • last month
Sutro Biopharma Announces First Cohort of Patients Dosed in Phase 1 Trial of STRO-004, a Next-Generation Tissue Factor ADC, in TF-Expressing Solid Tumors
Yahoo Finance • 2 months ago
Sutro Biopharma Highlights Next-Generation ADC Innovation at Virtual R&D Day
Yahoo Finance • 2 months ago
Sutro Biopharma Reports Third Quarter 2025 Financial Results and Business Highlights
About
CEO | Ms. Jane Chung R.Ph. |
Address | 111 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 178 |
